Elizabeth A Hoge

Summary

Affiliation: Massachusetts General Hospital
Country: USA

Publications

  1. pmc Randomized controlled trial of mindfulness meditation for generalized anxiety disorder: effects on anxiety and stress reactivity
    Elizabeth A Hoge
    Center for Anxiety and Traumatic Stress Disorders, Massachusetts General Hospital, One Bowdoin Sq, 6th Floor, Boston, MA 02114
    J Clin Psychiatry 74:786-92. 2013
  2. doi request reprint Loving-Kindness Meditation practice associated with longer telomeres in women
    Elizabeth A Hoge
    Department of Psychiatry, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA
    Brain Behav Immun 32:159-63. 2013
  3. pmc Plasma oxytocin immunoreactive products and response to trust in patients with social anxiety disorder
    Elizabeth A Hoge
    Department of Psychiatry, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts 02114, USA
    Depress Anxiety 29:924-30. 2012
  4. doi request reprint Effect of acute posttrauma propranolol on PTSD outcome and physiological responses during script-driven imagery
    Elizabeth A Hoge
    Department of Psychiatry, Massachusetts General Hospital, Boston, USA
    CNS Neurosci Ther 18:21-7. 2012
  5. ncbi request reprint Aripiprazole as augmentation treatment of refractory generalized anxiety disorder and panic disorder
    Elizabeth A Hoge
    Department of Psychiatry, Harvard Medical School, Boston, MA 02114, USA
    CNS Spectr 13:522-7. 2008
  6. ncbi request reprint Cross-cultural differences in somatic presentation in patients with generalized anxiety disorder
    Elizabeth A Hoge
    Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts 02114, USA
    J Nerv Ment Dis 194:962-6. 2006
  7. doi request reprint The role of anxiety sensitivity in sleep disturbance in panic disorder
    E A Hoge
    Department of Psychiatry, Massachusetts General Hospital, Boston, MA 02114 2790, USA
    J Anxiety Disord 25:536-8. 2011
  8. ncbi request reprint Resilience: research evidence and conceptual considerations for posttraumatic stress disorder
    Elizabeth A Hoge
    Department of Psychiatry, Massachusetts General Hospital, Boston, Massachusetts 02114, USA
    Depress Anxiety 24:139-52. 2007
  9. doi request reprint Oxytocin levels in social anxiety disorder
    Elizabeth A Hoge
    Department of Economics, Claremont University, Claremont, CA, USA
    CNS Neurosci Ther 14:165-70. 2008
  10. ncbi request reprint An open-label trial of risperidone augmentation for refractory anxiety disorders
    Naomi M Simon
    Center for Anxiety and Traumatic Stress Disorders, Massachusetts General Hospital, Boston, Mass, USA
    J Clin Psychiatry 67:381-5. 2006

Detail Information

Publications24

  1. pmc Randomized controlled trial of mindfulness meditation for generalized anxiety disorder: effects on anxiety and stress reactivity
    Elizabeth A Hoge
    Center for Anxiety and Traumatic Stress Disorders, Massachusetts General Hospital, One Bowdoin Sq, 6th Floor, Boston, MA 02114
    J Clin Psychiatry 74:786-92. 2013
    ....
  2. doi request reprint Loving-Kindness Meditation practice associated with longer telomeres in women
    Elizabeth A Hoge
    Department of Psychiatry, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA
    Brain Behav Immun 32:159-63. 2013
    ..Although limited by small sample size, these results offer the intriguing possibility that LKM practice, especially in women, might alter RTL, a biomarker associated with longevity...
  3. pmc Plasma oxytocin immunoreactive products and response to trust in patients with social anxiety disorder
    Elizabeth A Hoge
    Department of Psychiatry, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts 02114, USA
    Depress Anxiety 29:924-30. 2012
    ....
  4. doi request reprint Effect of acute posttrauma propranolol on PTSD outcome and physiological responses during script-driven imagery
    Elizabeth A Hoge
    Department of Psychiatry, Massachusetts General Hospital, Boston, USA
    CNS Neurosci Ther 18:21-7. 2012
    ..Previous studies have attempted to use pharmaceutical agents, especially the β-adrenergic blocker propranolol, to reduce this overconsolidation...
  5. ncbi request reprint Aripiprazole as augmentation treatment of refractory generalized anxiety disorder and panic disorder
    Elizabeth A Hoge
    Department of Psychiatry, Harvard Medical School, Boston, MA 02114, USA
    CNS Spectr 13:522-7. 2008
    ..Individuals with anxiety disorders often remain symptomatic despite treatment with a first-line pharmacologic agent. More research examining pharmacotherapy augmentation strategies to improve outcomes is needed...
  6. ncbi request reprint Cross-cultural differences in somatic presentation in patients with generalized anxiety disorder
    Elizabeth A Hoge
    Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts 02114, USA
    J Nerv Ment Dis 194:962-6. 2006
    ..Possible explanations include differences in cultural traditions of describing distress and the mind-body dichotomy...
  7. doi request reprint The role of anxiety sensitivity in sleep disturbance in panic disorder
    E A Hoge
    Department of Psychiatry, Massachusetts General Hospital, Boston, MA 02114 2790, USA
    J Anxiety Disord 25:536-8. 2011
    ..Our data suggest that sleep disturbance, and in particular sleep latency, in PD may be partly due to high levels of AS, which can be targeted with cognitive-behavioral therapeutic strategies...
  8. ncbi request reprint Resilience: research evidence and conceptual considerations for posttraumatic stress disorder
    Elizabeth A Hoge
    Department of Psychiatry, Massachusetts General Hospital, Boston, Massachusetts 02114, USA
    Depress Anxiety 24:139-52. 2007
    ....
  9. doi request reprint Oxytocin levels in social anxiety disorder
    Elizabeth A Hoge
    Department of Economics, Claremont University, Claremont, CA, USA
    CNS Neurosci Ther 14:165-70. 2008
    ..These findings may suggest a possible role for oxytocin as a facilitator of social behavior, an effect which may not be fully utilized in individuals with severe social anxiety...
  10. ncbi request reprint An open-label trial of risperidone augmentation for refractory anxiety disorders
    Naomi M Simon
    Center for Anxiety and Traumatic Stress Disorders, Massachusetts General Hospital, Boston, Mass, USA
    J Clin Psychiatry 67:381-5. 2006
    ..There is a paucity of data to support "next-step" treatments for the many patients with anxiety disorders who remain symptomatic after initial pharmacotherapy...
  11. pmc Next-step strategies for panic disorder refractory to initial pharmacotherapy: a 3-phase randomized clinical trial
    Naomi M Simon
    Center for Anxiety and Traumatic Stress Disorders, Massachusetts General Hospital, Simches Research Building, 2nd Floor, 185 Cambridge St, Boston, MA 02114, USA
    J Clin Psychiatry 70:1563-70. 2009
    ..More data are needed to guide next-step interventions for panic disorder refractory to initial intervention...
  12. ncbi request reprint Olanzapine augmentation of fluoxetine for refractory generalized anxiety disorder: a placebo controlled study
    Mark H Pollack
    Center for Anxiety and Traumatic Stress Related Disorders, Massachusetts General Hospital and Harvard Medical School, Boston, USA
    Biol Psychiatry 59:211-5. 2006
    ..We present one of the first randomized controlled trials for refractory GAD, comprising double blind augmentation with olanzapine or placebo for patients remaining symptomatic on fluoxetine...
  13. ncbi request reprint Preliminary support for gender differences in response to fluoxetine for generalized anxiety disorder
    Naomi M Simon
    Department of Psychiatry, Massachusetts General Hospital, Boston, MA 02114, USA
    Depress Anxiety 23:373-6. 2006
    ..Larger placebo-controlled trials are needed to more definitively examine gender and treatment response in anxiety disorders...
  14. doi request reprint Eszopiclone for the treatment of posttraumatic stress disorder and associated insomnia: a randomized, double-blind, placebo-controlled trial
    Mark H Pollack
    Center for Anxiety and Traumatic Stress Disorders, Massachusetts General Hospital, One Bowdoin Square, Sixth Floor, Boston, MA 02114, USA
    J Clin Psychiatry 72:892-7. 2011
    ..We present the first prospective, randomized, double-blind, placebo-controlled trial of a non-benzodiazepine hypnotic agent for the treatment of PTSD and associated insomnia...
  15. doi request reprint Quetiapine augmentation of paroxetine CR for the treatment of refractory generalized anxiety disorder: preliminary findings
    Naomi M Simon
    Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA
    Psychopharmacology (Berl) 197:675-81. 2008
    ..More data are needed to guide "next step" strategies for patients with generalized anxiety disorder (GAD) remaining symptomatic despite initial pharmacotherapy...
  16. pmc Stress reduction correlates with structural changes in the amygdala
    Britta K Hölzel
    Massachusetts General Hospital, Charlestown, MA 02129, USA
    Soc Cogn Affect Neurosci 5:11-7. 2010
    ....
  17. pmc Anchoring the Panic Disorder Severity Scale
    Meghan E Keough
    Massachusetts General Hospital, Boston, MA, USA
    Assessment 19:257-9. 2012
    ..These results provide further support for the validity and clinical utility of the PDSS and provide simple anchors to help guide the potential use of the PDSS scale to measure treatment progress in clinical practice...
  18. doi request reprint Open-label support for duloxetine for the treatment of panic disorder
    Naomi M Simon
    Department of Psychiatry, Center for Anxiety and Traumatic Stress Disorders, Massachusetts General Hospital, 185 Cambridge Street, Boston, MA 02114, USA
    CNS Neurosci Ther 15:19-23. 2009
    ....
  19. ncbi request reprint An open-label study of levetiracetam for the treatment of social anxiety disorder
    Naomi M Simon
    Center for Anxiety and Traumatic Stress Related Disorders, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA
    J Clin Psychiatry 65:1219-22. 2004
    ..Levetiracetam thus warrants systematic evaluation as a treatment option for anxiety disorders...
  20. doi request reprint A PET study of tiagabine treatment implicates ventral medial prefrontal cortex in generalized social anxiety disorder
    Karleyton C Evans
    Department of Psychiatry, Psychiatric Neuroscience Division, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02129, USA
    Neuropsychopharmacology 34:390-8. 2009
    ..Given the pharmacological profile of tiagabine, these findings suggest that its therapeutic effects in gSAD may be mediated by GABAergic modulation within the vmPFC...
  21. ncbi request reprint Fluoxetine for vestibular dysfunction and anxiety: a prospective pilot study
    Naomi M Simon
    Center for Anxiety and Traumatic Stress Related Disorders, Massachusetts General Hospital, WACC 815, Boston, MA 02114, USA
    Psychosomatics 46:334-9. 2005
    ..The data add to the literature suggesting a role for selective serotonin reuptake inhibitors in the treatment of dizziness and anxiety...
  22. ncbi request reprint Gender moderates the effect of oxytocin on social judgments
    Elizabeth A Hoge
    Department of Psychiatry, Massachusetts General Hospital, Boston, Massachusetts, USA Harvard Medical School, Boston, Massachusetts, USA
    Hum Psychopharmacol 29:299-304. 2014
    ..The neuropeptide oxytocin is implicated in social processing, and recent research has begun to explore how gender relates to the reported effects. This study examined the effects of oxytocin on social affective perception and learning...
  23. pmc Nest making and oxytocin comparably promote wound healing in isolation reared rats
    Antonia Vitalo
    Department of Surgery, Massachusetts General Hospital, Boston, Massachusetts, USA
    PLoS ONE 4:e5523. 2009
    ....